SCHEMBL28927992

SCHEMBL28927992

C=CCCN(c1ccc(Cl)cc1C(=C)c1ccccc1Cl)S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.45

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 11/20 0.45
PSEN2 P49810 11/20 0.45
APH1B Q8WW43 11/20 0.45
NCSTN Q92542 11/20 0.45
APH1A Q96BI3 11/20 0.45
PSENEN Q9NZ42 11/20 0.45
C5AR1 P21730 2/20 0.45
THRB P10828 1/20 0.42
MCOLN3 Q8TDD5 1/20 0.41
ESR1 P03372 2/20 0.40
PTGER1 P34995 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30059657 1.00 PSEN1 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL28927994 0.91 PSEN1 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL30058107 0.91 PSEN1 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL28962180 0.91 C5AR1 (0.43) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL30057618 0.89 C5AR1 (0.53) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL28928039 0.89 C5AR1 (0.53) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL30059432 0.88 PSEN1 (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL28928044 0.88 PSEN1 (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL28858222 0.85 PSEN1 (0.61) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL29143146 0.83 C5AR1 (0.50) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115557893-A Preparation method of sulfonyl-substituted 8-membered benzo [ b ] azepine Xin Huanhua compound 烟台大学 2023-01-03 CN claimed
CN-115557893-A Preparation method of sulfonyl-substituted 8-membered benzo [ b ] azepine Xin Huanhua compound 烟台大学 2023-01-03 CN disclosed